Apollomics Inc. Warrant (NASDAQ: APLMW) — Healthcare · Share Price, Chart & Market Data
About: Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.02 (+9.35%)
APLMWApollomics Inc. Warrant
Loading watchlist status…
Trade APLMW now
Apollomics Inc. Warrant share price
APLMW price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:03 pm GMT+0
APLMW price performance
4.11%
5D
9.353%
1M
-41.538%
YTD
-41.538%
1Y
APLMW price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:03 pm GMT+0
APLMW details
APLMW Market Signals